Sign in

What researchers published on Spinal muscular atrophy

942 papers, newest first.

Showing 120 of 942

  • Detecting motor changes in treated adults with spinal muscular atrophy using both MFM-32 and patient-reported outcome: a 2-year real-world retrospective study.Journal of neurology
  • Detection of Silent Carriers of Spinal Muscular Atrophy: A Survey of Clinical Practice and Recommendations for Screening.Twin research and human genetics : the official journal of the International Society for Twin Studies
  • Indirect treatment comparisons of nusinersen versus onasemnogene abeparvovec-brve in treatment-naïve and -experienced spinal muscular atrophy patients.Journal of medical economics
  • Quantitative Analysis of Branaplam (LMI070) in Human Plasma by LC-MS/MS in Support of Clinical Trial in Infant Patients With Spinal Muscular Atrophy (SMA).Biomedical chromatography : BMC
  • Trial resultA pre-post single-arm pilot trial of a digital multicomponent intervention for self-efficacy enhancement among online support groups of primary caregivers of children with neuro-muscular disorders: SEE-NMD protocol.PloS one
  • Neurofilaments as Biomarkers of Disease Activity and Treatment Response in Spinal Muscular Atrophy.European journal of neurology
  • ReviewEarly Independent Powered Mobility in Children With Severe Neuromuscular Disorders: A Scoping Review.Child: care, health and development
  • Dysregulation of dopamine metabolism in children with spinal muscular atrophy type 1.Brain communications
  • Paediatric palliative approach in the era of disease modifying therapies in spinal muscular atrophy - a comprehensive landscape of French specialist physicians' perspectives.Orphanet journal of rare diseases
  • Cost-Effectiveness Analysis of Newborn Screening for Spinal Muscular Atrophy in Argentina.Value in health regional issues
  • Use of European registries to characterise the changing landscape of disease progression and treatment of spinal muscular atrophy (SMA): opportunities, pitfalls and challenges.Orphanet journal of rare diseases
  • PCR hyper-automation: an example of spinal muscular atrophy and severe combined immunodeficiency screening.Clinical chemistry and laboratory medicine
  • Beyond motor rescue: defining adequate SMN restoration in spinal muscular atrophy.The Journal of clinical investigation
  • Early loss of axons limits the therapeutic window in a mouse model of spinal muscular atrophy.BMC neuroscience
  • Defining the clinical benefits of disease-modifying therapy in people living with spinal muscular atrophy who require permanent ventilation: a UK-based modified Delphi consensus process.EClinicalMedicine
  • Interval-based cycling for wheelchair users with spinal muscular atrophy: feasibility, tolerability, and exercise effects.Disability and rehabilitation. Assistive technology
  • Epidural Spinal Cord Stimulation Reduces Intrinsic Gait Abnormalities in Spinal Muscular Atrophy.Muscle & nerve
  • Beyond Gross Motor Function: The Association Between Fine Motor Skills and Cognitive Development in Treated SMA Type 1.Journal of clinical medicine
  • CCN1-mediated stress signaling underlies intrinsic cardiomyocyte dysfunction in spinal muscular atrophy.Cell reports
  • ReviewManagement of Hip Instability in Spinal Muscular Atrophy in the Disease-Modifying Therapy Era: The "Late Autumn" or "Early Spring" of Neuro-Orthopedics?Biomedicines
  • Myostatin/Smad3 in Spinal Muscular Atrophy: Biomarkers of Disease Severity and Treatment Response.Annals of clinical and translational neurology
  • ReviewCMAP as an electrophysiological biomarker in spinal muscular atrophy: A systematic review.Neurophysiologie clinique = Clinical neurophysiology
  • Randomised trialDietitian-Led Synchronous and Asynchronous Tele-Nutrition in Children With Spinal Muscular Atrophy: A Three-Arm Randomized Controlled Trial.Journal of human nutrition and dietetics : the official journal of the British Dietetic Association
  • ReviewMicrovasculopathy in spinal muscular atrophy: The endothelium as a target of SMN deficiency and an amplifier of disease.Neurobiology of disease
  • Pharmacological Activation of Autophagy Ameliorates Neuromuscular-Associated Defects and Extends Lifespan in a Caenorhabditis elegans Model of Spinal Muscular Atrophy.ACS chemical neuroscience
  • ReviewThe role of vascular pathology in SMA: implications for pathogenesis and treatment.Frontiers in cellular neuroscience
  • Serum p-tau181 and p-tau217 levels in adolescents and adults with 5q spinal muscular atrophy.Journal of neurology
  • Disease-specific body composition patterns in children with cerebral palsy and spinal muscular atrophy.Journal of pediatric gastroenterology and nutrition
  • Machine learning of connectome-wide functional connectivity in spinal muscular atrophy.Neuroscience
  • Machine learning predicts treatment response to nusinersen in non-sitter spinal muscular atrophy (SMA).Journal of neuromuscular diseases
  • Nationwide Implementation of Newborn Screening for Spinal Muscular Atrophy in Canada.Neurology. Genetics
  • Neurofilaments in cerebrospinal fluid and/or serum as a possible biomarker of pediatric spinal muscular atrophy.Journal of neuromuscular diseases
  • Provider Practice and Patient Clinical Follow-Up Among Patients With Spinal Muscular Atrophy (SMA) Linked-Variant.Prenatal diagnosis
  • Prevalence of Hypovitaminosis D and Its Association with Motor Impairment in Spinal Muscular Atrophy.Nutrients
  • Consensus on the Use of Intrathecal Gene Therapy for Spinal Muscular Atrophy.Neuropediatrics
  • Astrocyte SMN Restoration and Forskolin Treatment Improve SMA Synaptic Pathology.Annals of neurology
  • PreprintIncomplete cerebellar circuit restoration limits functional recovery following SMN therapy in severe spinal muscular atrophy.bioRxiv : the preprint server for biology
  • Case reportCase Report: Robot-assisted nissen fundoplication in spinal muscular atrophy type 2-a tailored surgical and anaesthetic strategy.Frontiers in surgery
  • Long-term real-world outcomes of nusinersen treatment in patients with spinal muscular atrophy types I-III.Brain & development
  • Clinical Practice of Single-Molecule Real-Time Sequencing in the Diagnosis of Spinal Muscular Atrophy.Molecular genetics & genomic medicine
  • Case reportSpinal Muscular Atrophy.Continuum (Minneapolis, Minn.)
  • Muscle biopsy to end a diagnostic odyssey in a genetically complex case of spinal muscular atrophy type 3: the importance of "old school" in the next-generation sequencing era.European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society
  • GuidelineConsensus for the Diagnosis and Treatment of Patients With Spinal Muscular Atrophy (SMA) in Latin America.Revista de neurologia
  • Impaired splicing of a conserved Pcyt2 minor intron in specific neuroglia contributes to spinal muscular atrophy.Science bulletin
  • Biphasic SMN condensates safeguard stress-induced cytoplasmic mislocalization of splicing RNPs.Cellular and molecular life sciences : CMLS
  • ReviewTherapeutic advances in spinal muscular atrophy: a review of clinical, safety, and economic considerations.Frontiers in pharmacology
  • Tissue-specific models of spinal muscular atrophy identify muscle functions required for Drosophila neuromuscular junction architecture.Human molecular genetics
  • Real-World Treatment Patterns in Patients with Spinal Muscular Atrophy Receiving Multiple Disease-Modifying Therapies.Advances in therapy
  • Unbiased bioinformatic and clinical analysis identifies glial fibrillary acidic protein as a potential biomarker in spinal muscular atrophy.Brain communications
  • Serum circulating cell-free messenger RNA profile response to risdiplam treatment in adult patients with late-onset spinal muscular atrophy.Brain communications
  • LRP12 CGG Repeat Expansions in Patients With Adult-Onset Non-5q Spinal Muscular Atrophy.Neurology. Genetics
  • Pharmacovigilance and network toxicology analysis of risdiplam-associated adverse events in pediatric patients with spinal muscular atrophy.Naunyn-Schmiedeberg's archives of pharmacology
  • Analytical Study Showing a False-Negative Limitation of Deletion-Based Newborn Screening for Spinal Muscular Atrophy Using a Compound Heterozygous SMN1 Control.International journal of neonatal screening
  • Initial Review of Government-Funded Reproductive Carrier Screening for Cystic Fibrosis, Spinal Muscular Atrophy and Fragile X Syndrome.Prenatal diagnosis
  • ReviewSpinal muscular atrophy as a blueprint for precision therapy in neuromuscular disease.Expert reviews in molecular medicine
  • The Management of Swallowing Disorders in Children With Spinal Muscular Atrophy Type 1: A Scoping Review.American journal of speech-language pathology
  • A Single-Tube Nested PCR Method for SMN1 Deletion Detection in Spinal Muscular Atrophy.Methods and protocols
  • Cost-Effectiveness of Newborn Screening for Spinal Muscular Atrophy in Spain, Greece, and Portugal.Neurology and therapy
  • Case reportCase Report: Presymptomatic risdiplam in preterm monozygotic twins with co-occurring spinal muscular atrophy and tuberous sclerosis complex.Frontiers in genetics
  • ReviewPathophysiology and biomaterials based therapeutic strategies for spinal muscular atrophy.In vitro models
  • Systematic reviewSpinal Muscular Atrophy, Sleep-Disordered Breathing, and the Effects of Disease-Modifying Therapies: A Narrative Review.Pediatric neurology
  • First myostatin-targeted antibody approved for spinal muscular atrophy.Nature reviews. Drug discovery
  • [Clinical analysis of nusinersen for spinal muscular atrophy types 2 and 3 in children].Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics
  • A changing early onset scoliosis phenotype in spinal muscular atrophy: nusinersen treatment is associated with younger age, increased curve magnitude, and kyphosis at the time of index surgery.Spine deformity
  • ReviewConsensus on gene therapy for spinal muscular atrophy in Taiwan.Journal of the Formosan Medical Association = Taiwan yi zhi
  • [Clinical analysis of spinal muscular atrophy complicated with hypoglycemia in 5 children].Zhonghua er ke za zhi = Chinese journal of pediatrics
  • Molecular diagnosis of spinal muscular atrophy: Experience in a pediatric hospital in Argentina.Archivos argentinos de pediatria
  • Educational workshop for caregivers of children with spinal muscular atrophy: A mixed-methods study.Archivos argentinos de pediatria
  • ReviewSpinal muscular atrophy: Biology, pathogenesis, and therapeutic advances.Therapeutic advances in neurological disorders
  • Gait Speed in Spinal Muscular Atrophy: A Key Vital Sign Linked to Strength and Fatigability.Muscle & nerve
  • Noninfectious meningitis related to nusinersen: a pharmacovigilance analysis using the WHO database.Neuromuscular disorders : NMD
  • UK SMA patient registry: a 3-year patient-reported outcome measures study supporting the drug appraisal of Nusinersen and Risdiplam in spinal muscular atrophy.Journal of the neurological sciences
  • ReviewSpinal muscular atrophy in the disease-modifying therapy era: successes, limitations and future directions.Frontiers in molecular medicine
  • Respiration during sleep in children with spinal muscular atrophy type 2 and 3, treated with nusinersen or risdiplam.Sleep medicine
  • Case reportDelayed diagnosis and genetic testing in spinal muscular atrophy: a case series.Annals of medicine
  • Humanistic and Economic Burden of Spinal Muscular Atrophy in the Gulf Region.Cureus
  • Meta-analysisA standardized framework resolves ambiguity in motor neuron loss across neurodegenerative diseases.Acta neuropathologica communications
  • "Shaky Hands, Weak Legs": Jerky Tremulousness as a Clue to Spinal Muscular Atrophy.Movement disorders clinical practice
  • Postural Torticollis and Early-Onset Scoliosis in Infants With SMA Identified Through Newborn Screening: Single Institution Experience.Muscle & nerve
  • Psychological symptoms in individuals with Spinal Muscular Atrophy (SMA) and their caregivers - results from a nation-wide study in Germany.Orphanet journal of rare diseases
  • Whole-Body Muscle MRI in Non-5q Spinal Muscular Atrophy: Patterns, Genotype Prediction, and Diagnostic Implications.Neurology. Genetics
  • Molecular Genetic Diagnosis of Spinal Muscular Atrophy: Clinical Utility, Challenges, and Lessons Learned from Illustrative Cases in a Single Center.Genes
  • Delphi consensus on gene therapy of spinal muscular atrophy with onasemnogene abeparvovec in Germany, Austria and Switzerland - part II - expert based recommendations for surveillance and management of side-effects.Journal of neuromuscular diseases
  • ReviewThe Prospective Regulatory Functions of lncRNAs and Their ceRNA Networks in the Development of Motor Neurons and Associated Diseases.Biomolecules
  • Case reportCase Report: Ultra-early nusinersen initiation with pre-procedural spinal ultrasound-assisted intrathecal access in a symptomatic neonate with spinal muscular atrophy.Frontiers in pediatrics
  • Immune cell-specific SMN expression and sustained immune alterations in treated spinal muscular atrophy.The Journal of clinical investigation
  • Impact of Intermittent Positive Pressure Breathing on Thoracic Growth in Children With Type 1 Spinal Muscular Atrophy.Pediatric pulmonology
  • Integrating LNA-qPCR and full-length SMN1 sequencing for precision SMA carrier screening: large-scale validation in 30,849 individuals.Clinica chimica acta; international journal of clinical chemistry
  • Real-world pharmacoclinical implementation of risdiplam under a national SMA protocol: A hospital pharmacy registry-based case series.Pakistan journal of pharmaceutical sciences
  • Generation and characterization of human induced pluripotent stem cell line AUSCIi001-A from spinal muscular atrophy patient.Stem cell research
  • From Genes to Function: Clinical Experience with the Effectiveness and Safety of Risdiplam and Nusinersen in Spinal Muscular Atrophy.Iranian journal of child neurology
  • The Spinal Muscular Atrophy Functional Classification System: First steps towards a functional classification in the era of disease-modifying therapy.Developmental medicine and child neurology
  • Response to Letter to the Editor Regarding "Safety and Efficacy of Magnetically Controlled Growing Rods for Early-Onset Scoliosis in the Era of Disease-Modifying Therapies: Mid-Term Results in a Homogeneous Cohort of Spinal Muscular Atrophy Type I Patients".Journal of the Pediatric Orthopaedic Society of North America
  • Anesthetic Management for Cesarean Delivery in a Pregnant Patient With Spinal Muscular Atrophy Type 2: A Case Report.Case reports in anesthesiology
  • Validation of proxy-reported EQ-5D-Y-3L in younger children with spinal muscular atrophy: age-related differences in performance.The European journal of health economics : HEPAC : health economics in prevention and care
  • Successful administration of glecaprevir/pibrentasvir via percutaneous endoscopic gastrostomy in a pediatric patient with chronic hepatitis C and spinal muscular atrophy receiving risdiplam.Clinical journal of gastroenterology
  • Assessment of Transition Plan Implementation and Provider Engagement Among Adults Living with Spinal Muscular Atrophy (SMA): Findings from a Cross-Sectional Survey.Neurology and therapy
  • Case reportGenetic susceptibility to thrombotic microangiopathy in a 10-month-old patient with SMA type 1: a caveat for gene therapy eligibility.Neuromuscular disorders : NMD
  • Gene therapy benefits in a small cohort of symptomatic 5q spinal muscular atrophy patients and real world pediatric outcomes.Jornal de pediatria
  • Case reportSpinal muscular atrophy with five SMN2 copies: Phenotypic heterogeneity and implications for newborn screening and treatment decisions.Frontiers in neurology
  • A Prospective, Multi-Site Study of Performance of Cell-Free DNA Testing for Recessive Conditions in a Large, General-Risk Pregnancy Population.Obstetrics and gynecology
  • ReviewTherapeutic strategies for spinal muscular atrophy: the history and future perspective.Frontiers in human neuroscience
  • The effect of GIP and GLP-2 on bone turnover in children with cerebral palsy or spinal muscular atrophy.Journal of the Endocrine Society
  • Effects of newborn screening and nusinersen on survival and functional outcomes in spinal muscular atrophy with two SMN2 copies: A nationwide multicentre real-world study from Turkey.European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society
  • Generic risdiplam and global spinal muscular atrophy care: opportunities and challenges in low- and middle-income countries (LMICs).Neuromuscular disorders : NMD
  • ReviewSurvival Motor Neuron Protein Requirement-Supply Mismatch in Spinal Muscular Atrophy: A Conceptual Framework.Advances in therapy
  • ReviewBotulinum Neurotoxin Treatment of Camptocormia- A Critical Review and Update.Tremor and other hyperkinetic movements (New York, N.Y.)
  • Longitudinal Dosing Patterns and Treatment Costs Among Patients with Spinal Muscular Atrophy Initiating Nusinersen and Risdiplam.Advances in therapy
  • Spinal muscular atrophy (SMA): early diagnosis, therapy and economic impact.European journal of hospital pharmacy : science and practice
  • Abnormal auditory neural activity in individuals with spinal muscular atrophy.Brain communications
  • The utilization of multiplex PCR with fragment analysis for carrier screening of spinal muscular atrophy.Clinica chimica acta; international journal of clinical chemistry
  • Glymphatic Dysfunction in Children With Type 2 and 3 Spinal Muscular Atrophy.CNS neuroscience & therapeutics
  • ReviewAddressing the Global Disparities in Access to Treatment in Spinal Muscular Atrophy.Muscle & nerve
  • Compound muscle action potential amplitudes in newborn screen positive spinal muscular atrophy.Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology
  • Nationwide Epidemiology of Motor Neuron Diseases in Latvia (2020-2024): Incidence, Prevalence, and Clinical Characteristics.European journal of neurology
  • Spinal Muscular Atrophy in Adult Neurology Services in India.Clinical genetics
  • Motor function score changes in severe 5q spinal muscular atrophy during risdiplam treatment: an observational longitudinal nationwide cohort study.EClinicalMedicine
  • Facial Nerve Thinning Correlates With Motor Function in Adults With Spinal Muscular Atrophy.Journal of neuroimaging : official journal of the American Society of Neuroimaging
  • Case reportA novel ASCC1 splice-site variant broadens the phenotypic spectrum of spinal muscular atrophy with congenital bone fractures type 2.Neuromuscular disorders : NMD
  • Sleep disordered breathing and autonomic outcomes in adult patients with spinal muscular atrophy (SMA) receiving Risdiplam.Sleep medicine